Shernan Holtan/roswellpark.org
Jul 27, 2025, 04:55
Shernan Holtan: Roswell Park Achieves 100% Six-Month Survival in 2024 Allogeneic Transplant Patients
Shernan Holtan, Chief of Blood and Marrow Transplantation and Professor of Medicine at Roswell Park Comprehensive Cancer Center, shared a post on X:
“We are proud to share a remarkable outcome at Roswell Park Comprehensive Cancer Center: 100% of patients who underwent allogeneic transplant in 2024 reached six-month survival. I never thought we would ever see such a statistic in our field.
We also roughly doubled our allo volumes during this time.
This milestone reflects the incredible adaptability of our group as they embraced new standards of care with skill and dedication, all while caring for more patients. Amazing.
I am beyond proud of this team!”
More posts featuring Shernan Holtan.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jul 27, 2025, 04:23
Jul 27, 2025, 04:16
Jul 27, 2025, 03:59
Jul 27, 2025, 03:44
Jul 27, 2025, 01:55
Jul 26, 2025, 21:46
Jul 26, 2025, 21:30
Jul 26, 2025, 21:09